BIOFLEX ISOPLASMA

This brand name is authorized in Nigeria.

Active ingredients

The drug BIOFLEX ISOPLASMA contains a combination of these active pharmaceutical ingredients (APIs):

1	Polyvinylpyrrolidone K30 UNII U725QWY32X - POVIDONE K30
2	Sodium UNII LYR4M0NH37 - SODIUM CATION
3	Potassium UNII 295O53K152 - POTASSIUM CATION

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-1334	Solution for injection/infusion	Bioflex Isoplasma INJ_SOL 100% 100 mL	Solution for Injection/Infusion	03/08/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05AA	Blood substitutes and plasma protein fractions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products
Discover more medicines within B05AA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-1334